Last reviewed · How we verify
Oral Rehydration Therapy — Competitive Intelligence Brief
marketed
Gastroenterology / Emergency Medicine
Small molecule
Live · refreshed every 30 min
Target snapshot
Oral Rehydration Therapy (Oral Rehydration Therapy) — Sanofi. Oral Rehydration Therapy (ORT) replaces lost fluids and electrolytes (sodium, potassium, chloride, glucose) through the small intestine to restore hydration and electrolyte balance.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Oral Rehydration Therapy TARGET | Oral Rehydration Therapy | Sanofi | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Oral Rehydration Therapy CI watch — RSS
- Oral Rehydration Therapy CI watch — Atom
- Oral Rehydration Therapy CI watch — JSON
- Oral Rehydration Therapy alone — RSS
Cite this brief
Drug Landscape (2026). Oral Rehydration Therapy — Competitive Intelligence Brief. https://druglandscape.com/ci/oral-rehydration-therapy. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab